MTSpace
Explorer
The bulk of forum threads tend to revolve around how people in the US, Canada, Europe, and Australia obtain GLP-1’s — be it via brand-name scripts, compounding pharmacies, or research vials shipped straight from Chinese labs.
Since China is behind the production of the overwhelming majority of these peptides, I’m curious what day-to-day reality looks like for users worldwide.
China: How widespread is GLP-1/peptide use among people living there? Are they mostly going through official hospital prescriptions, or is there a sizable direct-from-lab consumer scene inside China itself?
The Rest of the World: How does access play out across the Middle East, Latin America, Africa, and other parts of Asia (such as India, Japan, or South Korea)? Are folks turning to name-brand pens, locally made generics/compounds, or gray-market peptides?
If you’re based in any of these regions or have firsthand knowledge of how peptides are accessed there, I’d really like to hear your take!
A graph breaking down peptide usage by % across geographical territories would be fascinating to see.
Since China is behind the production of the overwhelming majority of these peptides, I’m curious what day-to-day reality looks like for users worldwide.
China: How widespread is GLP-1/peptide use among people living there? Are they mostly going through official hospital prescriptions, or is there a sizable direct-from-lab consumer scene inside China itself?
The Rest of the World: How does access play out across the Middle East, Latin America, Africa, and other parts of Asia (such as India, Japan, or South Korea)? Are folks turning to name-brand pens, locally made generics/compounds, or gray-market peptides?
If you’re based in any of these regions or have firsthand knowledge of how peptides are accessed there, I’d really like to hear your take!
A graph breaking down peptide usage by % across geographical territories would be fascinating to see.